Extracorporeal photopheresis (ECP) has been widely used as a second line therapy for
treatment of cGVHD with recognized efficacy as a steroid sparing intervention (2, 3). It is a …

Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …

Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …

DB and DK contributed to the work equally. Background Extracorporeal photopheresis
(ECP) is a recommended second or later line of therapy for chronic GVHD (cGVHD), and is …

Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …

Introduction: Graft-versus-host disease (GVHD) remains the most common cause of
morbidity and transplant-related mortality after allogeneic hematopoietic stem cell …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

Background Extracorporeal photopheresis (ECP) is considered a valid second-line
treatment for acute and chronic graft versus host disease (GVHD). Methods Ninety-four …